Concept and progress of shock treatment

doi:10.3877/cma.j.jssn.2096-1537.2015.01.013

Abstract

Abstract:

As one of the most common clinical phenomenon in the intensive care unit, shock is the clinical expression of circulatory failure that results in inadequate cellular oxygen utilization. Typically, shock can be diagnosed based on clinical, hemodynamic, and biochemical signs. Because of the various causes of shock, the underlying pathophysiological mechanisms are different. Appropriate treatment is based on a good understanding of the pathophysiological mechanisms in order to optimize the clinical outcomes.

Key words: Shock, Pathophysiology, Fluid resuscitation, Oxygen delivery, Vasoactive agent

Xiangdong Guan, Yao Nie. Concept and progress of shock treatment[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2015, 01(01): 53-57.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.jssn.2096-1537.2015.01.013

https://icu.cma-cmc.com.cn/EN/Y2015/V01/I01/53

References 30

[1]	Vincent JL, De Backer D. Circulatory shock[J]. N Engl J Med, 2013, 369(18):1726–1734.
[2]	Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock[J]. Crit Care Med, 2007, 35(9):2016–2024.
[3]	Corrêa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis[J]. Crit Care Med, 2012, 40(10):2841–2849.
[4]	Weil MH, Shubin H. The "VIP" approach to the bedside management of shock[J]. JAMA, 1969, 207(2):337–340.
[5]	Marik PE, Cavallazzi R, Vasu T, et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature[J]. Crit Care Med, 2009, 37(9):2642–2647.
[6]	Cavallaro F, Sandroni C, Marano C, et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and meta-analysis of clinical studies[J]. Intensive Care Med, 2010, 36(9):1475–1483.
[7]	Delaney AP, Dan A, McCaffrey J, et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2011, 39(2):386–391.
[8]	Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2):580–637.
[9]	Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group[J]. Lancet, 2000, 356(9248):2139–2143.
[10]	De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock[J]. N Engl J Med, 2010, 362(9):779–789.
[11]	De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis[J]. Crit Care Med, 2012, 40(3):725–730.
[12]	Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: A prospective, randomized pilot study[J]. Crit Care Med, 2011, 39(3):450–455.
[13]	Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial[J]. Lancet, 2007, 370(9588):676–684.
[14]	Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients[J]. Intensive Care Med, 2008, 34(12):2226–2234.
[15]	TRIUMPH Investigators, Alexander JH, Reynolds HR, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial[J]. JAMA, 2007, 297(15):1657–1666
[16]	López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock[J]. Crit Care Med, 2004, 32(1):21–30.
[17]	Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358(9):877–887.
[18]	Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock[J]. Crit Care Med, 2009, 37(3):811–818.
[19]	De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects[J]. Crit Care Med, 2006, 34(2):403–408.
[20]	Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial[J]. Am J Respir Crit Care Med, 2010, 182(6):752–761.
[21]	Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline[J]. Crit Care, 2013, 17(2):R76.
[22]	Vincent JL, Rhodes A, Perel A, et al. Clinical review: Update on hemodynamic monitoring -- a consensus of 16[J]. Crit Care, 2011, 15(4):229.
[23]	Vincent JL. Understanding cardiac output[J]. Crit Care, 2008, 12(4):174.
[24]	Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19):1368–1377.
[25]	Vincent JL, Dufaye P, Berré J, et al. Serial lactate determinations during circulatory shock[J]. Crit Care Med, 1983, 11(6):449–451.
[26]	De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference[J]. Crit Care, 2007, 11(5):R101.
[27]	Gómez H, Torres A, Polanco P, et al. Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O2 saturation response[J]. Intensive Care Med, 2008, 34(9):1600–1607.
[28]	Creteur J, Carollo T, Soldati G, et al. The prognostic value of muscle StO2 in septic patients[J]. Intensive Care Med, 2007, 33(9):1549–1556.
[29]	Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med, 2012, 367(14):1287–1296.
[30]	Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock[J]. Crit Care Med, 2008, 36(5):1404–1411.

Please choose a citation manager

Content to export